| Trial Status | Closed for recruitment |
| Dates | Date of activation: 23-Mar-09 Closed on : 12-Apr-13 |
| Data management at EORTC | Mailbox |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: 200 - All Groups: 1656 |
| Number of steps | 1 |
| Drug | Sorafenib |
| Study Staff | Steven Joniau (Study Coordinator) - U.Z. Leuven - Campus Gasthuisberg, Leuven Richard Sylvester (Statistician) - EORTC Headquarters, Brussels Maarten De Rouck (Data Manager) - EORTC Headquarters, Brussels Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels Julie Hermans (Project Manager) - EORTC Headquarters, Brussels, julie.hermans( at )eortc.be, +32 27741673 |
| Type of cancer | Kidney |
| Participating Groups | Medical Research Council Clinical Trial Unit(Coordinating Group) EORTC Genito-Urinary Cancers Group |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00492258 |
| EudraCT | 2006-006079-19 |
| Protocol documents in PDF (requires password) | Study documentation |